Home
About Us
Company Profile
HIstory
Culture
Honor
Products
Cardiovascular series
Psychiatry series
Hepatobiliary, Gastroenterology Series
Respiratory series
Anti-infective virus series
Other series
Large Infusion Series
Huabao Tong Series
Active Pharmaceutical Ingredient Series
R&D
Academician Expert Workstation
Medical Research and Industry Alliance
News
General News
Party group dynamics
Employee activity
HR
Talent Strategy
Company recruitment
Contact us
中文版
Date:
29 Aug,2022
5 Month, Acquiring Tangshan Bohai Pharmaceutical Co., Ltd.
Previous page
2009
2004
Next page
Related Recommendations
2023/03/24
Public Notice for the 2,195-Ton Annual Production Project of Active Pharmaceutical Ingredients (Phase I) by Wanbangde Pharmaceutical Group Co., Ltd.
March blooms with flowers—time to embrace passion and blossom into your finest selves. | @To all the Wanbande goddesses, hurry over and receive this most beautiful wish!
2023/02/27
Industry-Education Integration and School-Enterprise Collaboration | Wanbangde Pharmaceutical Group Successfully Selected for the "2021–2022 Zhejiang Province Industry-Education Integrated Enterprise" List!